{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:04:20Z","timestamp":1758845060903,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.urology.2023.08.037","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T11:48:29Z","timestamp":1695037709000},"page":"175-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of Agent Orange Exposure on Non-muscle Invasive Bladder Cancer Outcomes"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8800-8109","authenticated-orcid":false,"given":"Taylor","family":"Penn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tudor","family":"Borza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinn-ing","family":"Liou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Jason Abel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Jarrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle A.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2023.08.037_bib1","unstructured":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides (Eleventh Biennial Update). Veterans and Agent Orange: Update 11 (2018). National Academies Press (US); November 15, 2018. https:\/\/www.doi.org\/10.17226\/25137."},{"key":"10.1016\/j.urology.2023.08.037_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01537","article-title":"The extent and patterns of usage of Agent Orange and other herbicides in Vietnam","volume":"422","author":"Stellman","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.urology.2023.08.037_bib3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/aje\/153.11.1031","article-title":"Health effects of dioxin exposure: a 20-year mortality study","volume":"153","author":"Bertazzi","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urology.2023.08.037_bib4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0140-6736(91)91835-I","article-title":"Cancer mortality among workers in chemical plant contaminated with dioxin","volume":"338","author":"Manz","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2023.08.037_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1056\/NEJM199101243240402","article-title":"Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"324","author":"Fingerhut","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2023.08.037_bib6","unstructured":"U.S. Department of Veterans Affairs, VA Benefits and Health Care: Agent Orange exposure and VA disability compensation. Updated June 15, 2021. Accessed November 23, 2021. \u3008https:\/\/www.va.gov\/disability\/eligibility\/hazardous-materials-exposure\/agent-orange\/\u3009."},{"key":"10.1016\/j.urology.2023.08.037_bib7","unstructured":"H.R.6395 - 116th Congress (2019\u20132020): William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021. 2021. Accessed November 23, 2021 \u3008https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/6395\u3009."},{"key":"10.1016\/j.urology.2023.08.037_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/carcin\/bgp222","article-title":"Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer","volume":"31","author":"Ishida","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.urology.2023.08.037_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1073\/pnas.0706183104","article-title":"Dioxin-mediated tumor progression through activation of mitochondria-to-nucleus stress signaling","volume":"105","author":"Biswas","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urology.2023.08.037_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1289\/ehp.11781","article-title":"Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding","volume":"117","author":"Milbrath","year":"2009","journal-title":"Environ Health Persp"},{"key":"10.1016\/j.urology.2023.08.037_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00121331","article-title":"Long-term carcinogenesis studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin and hexachlorodibenzo-p-dioxins","volume":"7","author":"Huff","year":"1991","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.urology.2023.08.037_bib12","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1002\/cncr.28961","article-title":"Agent Orange exposure and cancer incidence in Korean Vietnam veterans: a prospective cohort study","volume":"120","author":"Yi","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2023.08.037_bib13","unstructured":"Australian Institute of Health and Welfare: Cancer Incidence in Australian Vietnam Veterans Study 2005. Canberra; 2005."},{"key":"10.1016\/j.urology.2023.08.037_bib14","unstructured":"Australian Institute of Health and Welfare: The Third Australian Vietnam Veterans Mortality Study 2005. Canberra; 2005."},{"key":"10.1016\/j.urology.2023.08.037_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.jom.0000111603.84316.0f","article-title":"Cancer in US Air Force veterans of the Vietnam War","volume":"46","author":"Akhtar","year":"2004","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.urology.2023.08.037_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ije\/20.1.7","article-title":"Cancer surveillance of veterans in Massachusetts, USA, 1982-1988","volume":"20","author":"Clapp","year":"1991","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.urology.2023.08.037_bib17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ije\/26.3.679","article-title":"Update of cancer surveillance of veterans in Massachusetts, USA","volume":"26","author":"Clapp","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.urology.2023.08.037_bib18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnci\/91.9.779","article-title":"Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"91","author":"Steenland","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2023.08.037_bib19","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/ije\/dyu183","article-title":"Agent orange exposure and risk of death in Korean Vietnam veterans: Korean veterans health study","volume":"43","author":"Yi","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.urology.2023.08.037_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.kjms.2015.05.005","article-title":"Bacille Calmette-Guerin can induce cellular apoptosis of urothelial cancer directly through toll-like receptor 7 activation","volume":"31","author":"Yu","year":"2015","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.urology.2023.08.037_bib21","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2174\/1871520620666200502004002","article-title":"The apoptosis mechanism of epirubicin combined with BCG on human bladder cancer cells","volume":"20","author":"Luo","year":"2020","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"10.1016\/j.urology.2023.08.037_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2020.110393","article-title":"Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect","volume":"129","author":"Han","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.urology.2023.08.037_bib23","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1158\/0008-5472.CAN-04-0374","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Gu\u00e9rin-induced antitumor activity","volume":"64","author":"Ludwig","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2023.08.037_bib24","unstructured":"Department of Veterans Affairs, Office of Data Governance and Analytics, Veteran Population Projection Model (VetPop) 2018; Veterans Benefits Administration; Veterans Health Administration, Office of the Assistant Deputy Under Secretary for Health for Policy and Planning: Department of Veterans Affairs Statistics at a Glance. Updated December 31, 2020. Accessed November 23, 2021. \u3008https:\/\/www.va.gov\/vetdata\/docs\/Quickfacts\/Stats_at_a_glance_12_31_20.PDF\u3009."},{"key":"10.1016\/j.urology.2023.08.037_bib25","unstructured":"U.S. Department of Veterans Affairs, Health Services Research and Development: VA Informatics and Computing Infrastructure (VINCI). Accessed November 24, 2021 \u3008https:\/\/www.hsrd.research.va.gov\/for_researchers\/vinci\/\u3009."},{"key":"10.1016\/j.urology.2023.08.037_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.urology.2020.07.023","article-title":"Increased bacillus Calmette-Guerin treatment intensity associated with improved outcomes in elderly patients with non-muscle invasive bladder cancer in United States Clinical Practice","volume":"145","author":"Richards","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.urology.2023.08.037_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.urology.2023.08.037_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","volume":"15","author":"Pettenati","year":"2008","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urology.2023.08.037_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/sj.jea.7500331","article-title":"Exposure opportunity models for Agent Orange, dioxin, and other military herbicides used in Vietnam, 1961-1971","volume":"14","author":"Stellman","year":"2004","journal-title":"J Expo Anal Environ Epidemiol"},{"year":"2008","series-title":"The Utility of Proximity-Based Herbicide Exposure Assessment in Epidemiologic Studies of Vietnam Veterans","key":"10.1016\/j.urology.2023.08.037_bib30"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952300794X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952300794X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:17:28Z","timestamp":1758770248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042952300794X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":30,"alternative-id":["S009042952300794X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2023.08.037","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Agent Orange Exposure on Non-muscle Invasive Bladder Cancer Outcomes","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2023.08.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}